Page 7 - Rensselaer Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Effort intensifies to identify novel mechanisms and targets for future Alzheimer’s therapeutics
A new grant from the National Institute On Aging at the National Institutes of Health will support ongoing research at Rensselaer Polytechnic Institute to address Alzheimer’s disease caused by gene mutations. According to Chunyu Wang, the principal investigator and an assistant professor of biological sciences at Rensselaer, the project seeks to understand and counter the mechanism that produces Amyloid-Beta 42 peptide in brain cells.
“A key pathology in Alzheimer’s is accumulation of senile plaque in the brain, which is mainly composed of the Amyloid Beta-42 peptide,” said Wang, who is a member of the Rensselaer Center for Biotechnology and Interdisciplinary Studies. “This grant supports research into an enzyme that is responsible for producing the toxic peptide using single molecule techniques, and may identify novel mechanisms and targets for future Alzheimer’s ....

Chunyu Wang , National Institutes Of Health , National Institute On , Rensselaer Polytechnic Institute , Rensselaer Center , National Institute On Aging , National Institutes , Scott Forth , Familial Alzheimer , Amyloid Beta , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , தேசிய நிறுவனம் ஆன் , ரென்சீலர் பாலிடெக்நிக் நிறுவனம் , ரென்சீலர் மையம் , தேசிய நிறுவனங்கள் , ஸ்காட் முன்னால் , குடும்ப முதுமறதி ,